AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (729)	9/10/1997 10:14:00 AM
From: Andrew H	of 2173

OTOTOT--Richard, I'm sure Henry will answer these questions if he hasn't already. With the recent conversations here, I think the LGND thread might be a better place to discuss these matters. In any case I rely on Henry for my scientific info in regard to LGND. Regarding leptin deal, IR has it that the lawyers are still working out the details. Regarding Targretin vs ALRT for diabetes, it is my understanding that in preclinicals a couple of the ALRT compounds (don't know their specific numerical designations) show more power than Targretin in regard to diabetes, but they have not entered trials yet. So for now its Targretin for diabetes, but looks like new and more potent diabetes coumpounds are in the pipeline. Henry can fill you in on the specifics. Apologies to the thread for posting this here. From now on will stick to AMLN here.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next